




Searching News Database: RRa
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 31 Mar 2025
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
HSMN NewsFeed - 7 Mar 2025
Zimmer Biomet Receives FDA Clearance for Persona(R) Revision SoluTion(TM) Femur
Zimmer Biomet Receives FDA Clearance for Persona(R) Revision SoluTion(TM) Femur
HSMN NewsFeed - 6 Mar 2025
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
HSMN NewsFeed - 30 Jan 2025
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
HSMN NewsFeed - 24 Jan 2025
Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors
Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors
HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
HSMN NewsFeed - 22 Aug 2024
Stratus Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom
Stratus Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom
HSMN NewsFeed - 21 Aug 2024
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
HSMN NewsFeed - 25 Apr 2024
Provisio Medical Announces FDA Clearance of the Provisio SLT IVUS(TM) System
Provisio Medical Announces FDA Clearance of the Provisio SLT IVUS(TM) System
HSMN NewsFeed - 3 Apr 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
HSMN NewsFeed - 29 Mar 2024
RIVANNA(R) Appoints Craig Loomis as Senior Director of Product Management
RIVANNA(R) Appoints Craig Loomis as Senior Director of Product Management
HSMN NewsFeed - 22 Jan 2024
CalciMedica Announces Private Placement of up to Approximately $55 Million
CalciMedica Announces Private Placement of up to Approximately $55 Million
HSMN NewsFeed - 17 Jan 2024
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
HSMN NewsFeed - 14 Dec 2023
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
HSMN NewsFeed - 20 Nov 2023
FDA Grants Orphan Drug Designation to NeoImmuneTech's NT-I7 for the Treatment of Acute Radiation Syndrome
FDA Grants Orphan Drug Designation to NeoImmuneTech's NT-I7 for the Treatment of Acute Radiation Syndrome
HSMN NewsFeed - 7 Nov 2023
Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot
Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot
HSMN NewsFeed - 31 Oct 2023
Ortho Development(R) Announces Launch of the BKS(R) Uni Partial Knee System
Ortho Development(R) Announces Launch of the BKS(R) Uni Partial Knee System
HSMN NewsFeed - 11 Oct 2023
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
HSMN NewsFeed - 6 Sep 2023
OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
HSMN NewsFeed - 26 Jul 2023
iotaMotion Completes $12M Series A Raise to Accelerate Commercial Expansion of iotaSOFT(R) Insertion System
iotaMotion Completes $12M Series A Raise to Accelerate Commercial Expansion of iotaSOFT(R) Insertion System
HSMN NewsFeed - 19 May 2023
Abbott Receives FDA Approval for TactiFlex(TM) Ablation Catheter for Treatment of Abnormal Heart Rhythm
Abbott Receives FDA Approval for TactiFlex(TM) Ablation Catheter for Treatment of Abnormal Heart Rhythm
HSMN NewsFeed - 30 Mar 2023
FDA approves Bioretec's RemeOs(TM) trauma screw as the first bioresorbable metal implant in the U.S. market
FDA approves Bioretec's RemeOs(TM) trauma screw as the first bioresorbable metal implant in the U.S. market
HSMN NewsFeed - 27 Dec 2022
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
HSMN NewsFeed - 12 Dec 2022
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
HSMN NewsFeed - 18 Nov 2022
Synaptogenix Announces $15 Million Private Placement with Existing Investors
Synaptogenix Announces $15 Million Private Placement with Existing Investors
HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
HSMN NewsFeed - 23 Aug 2022
IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
HSMN NewsFeed - 29 Jun 2022
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
HSMN NewsFeed - 29 Jun 2022
Invictus' Aura Storm Air Purifier Receives FDA 510(k) Class II Medical Device Clearance
Invictus' Aura Storm Air Purifier Receives FDA 510(k) Class II Medical Device Clearance
HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
HSMN NewsFeed - 29 Apr 2022
OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer
OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer
HSMN NewsFeed - 26 Apr 2022
Halozyme Commences Tender Offer for All Outstanding Shares of Common Stock of Antares Pharma
Halozyme Commences Tender Offer for All Outstanding Shares of Common Stock of Antares Pharma
HSMN NewsFeed - 13 Apr 2022
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
HSMN NewsFeed - 4 Apr 2022
Invitae Introduces First Comprehensive Genetic Test Suite for Neurodevelopmental Disorders
Invitae Introduces First Comprehensive Genetic Test Suite for Neurodevelopmental Disorders
HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
HSMN NewsFeed - 7 Feb 2022
Zimmer Biomet Announces Expected Completion Date of March 1, 2022 for Spinoff of ZimVie
Zimmer Biomet Announces Expected Completion Date of March 1, 2022 for Spinoff of ZimVie
HSMN NewsFeed - 3 Jan 2022
Zynex Submits FDA Application for its Next Generation Fluid and Blood Volume Monitor
Zynex Submits FDA Application for its Next Generation Fluid and Blood Volume Monitor
HSMN NewsFeed - 16 Nov 2021
Sonendo Announces Alma Salazar as Associate Vice President, Professional and Consumer Marketing
Sonendo Announces Alma Salazar as Associate Vice President, Professional and Consumer Marketing
HSMN NewsFeed - 8 Oct 2021
Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM
Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM
HSMN NewsFeed - 13 Sep 2021
SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
HSMN NewsFeed - 9 Sep 2021
B dot Medical Successfully Develops Compact Scanning Magnet for Proton Cancer Therapy System
B dot Medical Successfully Develops Compact Scanning Magnet for Proton Cancer Therapy System
HSMN NewsFeed - 30 Aug 2021
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
HSMN NewsFeed - 21 Jul 2021
PathogenDx Receives CE-IVD Mark for Its Microarray-Based DetectX-Rv Test for COVID-19
PathogenDx Receives CE-IVD Mark for Its Microarray-Based DetectX-Rv Test for COVID-19
HSMN NewsFeed - 28 Jun 2021
B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting Technology
B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting Technology
HSMN NewsFeed - 22 Jun 2021
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
HSMN NewsFeed - 17 Jun 2021
Lilly Launches Think Talk Treat Migraine(TM) to Help Improve Diagnosis and Treatment of Migraine
Lilly Launches Think Talk Treat Migraine(TM) to Help Improve Diagnosis and Treatment of Migraine
HSMN NewsFeed - 1 Jun 2021
Kineta Closes $10 Million Financing Round to Advance Anti-VISTA Immuno-oncology Program
Kineta Closes $10 Million Financing Round to Advance Anti-VISTA Immuno-oncology Program
HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
HSMN NewsFeed - 19 Apr 2021
Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS
Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS
HSMN NewsFeed - 15 Apr 2021
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
HSMN NewsFeed - 13 Apr 2021
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
HSMN NewsFeed - 26 Mar 2021
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
HSMN NewsFeed - 1 Mar 2021
Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 16 Feb 2021
Zeiss Presents Digital Microscope with Extended Depth of Field in Real Time
Zeiss Presents Digital Microscope with Extended Depth of Field in Real Time
HSMN NewsFeed - 29 Dec 2020
Collagen Matrix Acquires the GUIDOR(R) Synthetic Bone Graft & Membrane Business from Sunstar
Collagen Matrix Acquires the GUIDOR(R) Synthetic Bone Graft & Membrane Business from Sunstar
HSMN NewsFeed - 22 Dec 2020
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
HSMN NewsFeed - 17 Dec 2020
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 19 Nov 2020
LimaCorporate Announces FDA Approval for an IDE Study on SMR Stemless Reverse Shoulder System
LimaCorporate Announces FDA Approval for an IDE Study on SMR Stemless Reverse Shoulder System
HSMN NewsFeed - 2 Nov 2020
Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions
Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions
HSMN NewsFeed - 7 Oct 2020
Exact Sciences and Pfizer Extend and Amend Cologuard(R) Promotion Agreement
Exact Sciences and Pfizer Extend and Amend Cologuard(R) Promotion Agreement
HSMN NewsFeed - 4 Sep 2020
I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium
I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium
HSMN NewsFeed - 25 Aug 2020
Smith & Nephew Launches ARIA Care Management Platform for Patients and Providers
Smith & Nephew Launches ARIA Care Management Platform for Patients and Providers
HSMN NewsFeed - 18 Aug 2020
Innovent and Lilly Announce Expansion of TYVYT(R) (Sintilimab Injection) Licensing Agreement
Innovent and Lilly Announce Expansion of TYVYT(R) (Sintilimab Injection) Licensing Agreement
HSMN NewsFeed - 11 Aug 2020
IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System
IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System
HSMN NewsFeed - 30 Jun 2020
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
HSMN NewsFeed - 22 Jun 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
HSMN NewsFeed - 18 Jun 2020
NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity
NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity
HSMN NewsFeed - 15 Jun 2020
IRRAS Announces Promotion of Will Martin to President and Chief Commercial Officer
IRRAS Announces Promotion of Will Martin to President and Chief Commercial Officer
HSMN NewsFeed - 4 Jun 2020
Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round
Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round
HSMN NewsFeed - 29 May 2020
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
HSMN NewsFeed - 26 May 2020
Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
HSMN NewsFeed - 13 Apr 2020
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin(R) Gel 80 U/mL
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin(R) Gel 80 U/mL
HSMN NewsFeed - 6 Apr 2020
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren(R) Arthritis Pain
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren(R) Arthritis Pain
HSMN NewsFeed - 25 Mar 2020
University of Helsinki, a Global Neurosurgery Leader and IRRAS Will Collaborate to Advance Uses of IRRAflow
University of Helsinki, a Global Neurosurgery Leader and IRRAS Will Collaborate to Advance Uses of IRRAflow
HSMN NewsFeed - 20 Mar 2020
Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan(TM) Esophageal Implant
Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan(TM) Esophageal Implant
HSMN NewsFeed - 16 Mar 2020
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
HSMN NewsFeed - 2 Mar 2020
ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
HSMN NewsFeed - 19 Feb 2020
ZAP Surgical to Bring World-Class Brain Tumor Treatments to Rural German Hospital
ZAP Surgical to Bring World-Class Brain Tumor Treatments to Rural German Hospital
HSMN NewsFeed - 10 Feb 2020
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
HSMN NewsFeed - 7 Feb 2020
Perrigo Announces Consumer Self-Care Americas Segment Leadership Transition
Perrigo Announces Consumer Self-Care Americas Segment Leadership Transition
HSMN NewsFeed - 3 Feb 2020
A Revolution in Laparoscopic Training: KARL STORZ and VirtaMed Leap Beyond VR Simulation
A Revolution in Laparoscopic Training: KARL STORZ and VirtaMed Leap Beyond VR Simulation
HSMN NewsFeed - 3 Feb 2020
Truvian Sciences Appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering
Truvian Sciences Appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering
HSMN NewsFeed - 30 Jan 2020
Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
HSMN NewsFeed - 29 Jan 2020
Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application
Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application
HSMN NewsFeed - 16 Jan 2020
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
HSMN NewsFeed - 7 Jan 2020
HeartBeam Appoints Rich Ferrari and Marga Ortigas-Wedekind to its Board of Directors
HeartBeam Appoints Rich Ferrari and Marga Ortigas-Wedekind to its Board of Directors
HSMN NewsFeed - 7 Jan 2020
IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020
IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020
HSMN NewsFeed - 30 Dec 2019
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
HSMN NewsFeed - 19 Dec 2019
Michigan Community Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
Michigan Community Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
HSMN NewsFeed - 18 Dec 2019
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
HSMN NewsFeed - 5 Nov 2019
Nevro Announces U.S. Launch of Senza(R) Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain
Nevro Announces U.S. Launch of Senza(R) Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain
HSMN NewsFeed - 31 Oct 2019
Baylis Medical Introduces a 2-French Electrophysiology Catheter into North America
Baylis Medical Introduces a 2-French Electrophysiology Catheter into North America
HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
HSMN NewsFeed - 28 Oct 2019
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
HSMN NewsFeed - 23 Oct 2019
NeuroRx Secures HK$ 750 Million Capital Commitment From The Gem Group for Development of NRX-101
NeuroRx Secures HK$ 750 Million Capital Commitment From The Gem Group for Development of NRX-101
HSMN NewsFeed - 30 Sep 2019
Sobi to Acquire Dova Pharmaceuticals Creating a Global Growth Platform in Haematology
Sobi to Acquire Dova Pharmaceuticals Creating a Global Growth Platform in Haematology
HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
HSMN NewsFeed - 23 Sep 2019
Cologuard(R) Gains FDA Approval For Use In Younger Americans, Ages 45 To 49
Cologuard(R) Gains FDA Approval For Use In Younger Americans, Ages 45 To 49
HSMN NewsFeed - 18 Sep 2019
Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019
Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019
HSMN NewsFeed - 30 Aug 2019
Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering
Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering
HSMN NewsFeed - 12 Aug 2019
Shimadzu Medical Systems receives FDA 510(k) for the FLUOROspeed X1 RF system
Shimadzu Medical Systems receives FDA 510(k) for the FLUOROspeed X1 RF system
HSMN NewsFeed - 6 Aug 2019
SofWave Medical Closes $8.4M Financing Round; Announces Appointment of Louis Scafuri to CEO Position
SofWave Medical Closes $8.4M Financing Round; Announces Appointment of Louis Scafuri to CEO Position
HSMN NewsFeed - 30 Jul 2019
Alfa Plus by Solio Receives FDA Clearance: Unique Device Delivers Pain Relief Without Pharmaceuticals
Alfa Plus by Solio Receives FDA Clearance: Unique Device Delivers Pain Relief Without Pharmaceuticals
HSMN NewsFeed - 29 Jul 2019
Hillrom Introduces Next-Generation Breakthrough Technology In Fight Against Diabetic Retinopathy
Hillrom Introduces Next-Generation Breakthrough Technology In Fight Against Diabetic Retinopathy
HSMN NewsFeed - 10 Jul 2019
NuVasive Launches Pulse(TM) - the First Integrated Technology Platform to Enable Better Spine Surgery
NuVasive Launches Pulse(TM) - the First Integrated Technology Platform to Enable Better Spine Surgery
HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
HSMN NewsFeed - 25 Jun 2019
SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer
SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer
HSMN NewsFeed - 12 Jun 2019
CutisPharma Announces Acquisition Of Silvergate Pharmaceuticals, Name Change To Azurity Pharmaceuticals
CutisPharma Announces Acquisition Of Silvergate Pharmaceuticals, Name Change To Azurity Pharmaceuticals
HSMN NewsFeed - 21 May 2019
Perrigo Announces FDA Final Approval For AB Rated Generic Version Of Voltaren(R) Gel 1%
Perrigo Announces FDA Final Approval For AB Rated Generic Version Of Voltaren(R) Gel 1%
HSMN NewsFeed - 24 Apr 2019
Xstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at ESTRO 2019
Xstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at ESTRO 2019
HSMN NewsFeed - 15 Apr 2019
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
HSMN NewsFeed - 10 Apr 2019
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12
HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
HSMN NewsFeed - 15 Mar 2019
Fujifilm Launches Three New Software Tools For Its ASPIRE Cristalle Digital Mammography System
Fujifilm Launches Three New Software Tools For Its ASPIRE Cristalle Digital Mammography System
HSMN NewsFeed - 11 Mar 2019
IRRAS Strengthens Executive Team With Addition of Dr. Vinny Podichetty as Vice President of Clinical Affairs
IRRAS Strengthens Executive Team With Addition of Dr. Vinny Podichetty as Vice President of Clinical Affairs
HSMN NewsFeed - 11 Feb 2019
FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
HSMN NewsFeed - 16 Jan 2019
Terumo Introduces Its Smallest, Lowest Prime Volume, Full-Size Adult* Capiox(R) Oxygenator
Terumo Introduces Its Smallest, Lowest Prime Volume, Full-Size Adult* Capiox(R) Oxygenator
HSMN NewsFeed - 4 Jan 2019
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
HSMN NewsFeed - 2 Jan 2019
LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
HSMN NewsFeed - 17 Dec 2018
Proteostasis Therapeutics Announces Global License Agreement with Genentech
Proteostasis Therapeutics Announces Global License Agreement with Genentech
HSMN NewsFeed - 12 Dec 2018
Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets
Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets
HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
HSMN NewsFeed - 29 Nov 2018
Nuvo Pharmaceuticals(TM) Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
Nuvo Pharmaceuticals(TM) Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
HSMN NewsFeed - 19 Nov 2018
RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.
RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.
HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
HSMN NewsFeed - 16 Oct 2018
Precision For Medicine Acquires Liquid Biopsy And Tissue Profiling Pioneer ApoCell
Precision For Medicine Acquires Liquid Biopsy And Tissue Profiling Pioneer ApoCell
HSMN NewsFeed - 8 Oct 2018
CSA Medical Secures $23 Million to Advance its Cryospray(TM) Therapies for Esophageal Disease and COPD
CSA Medical Secures $23 Million to Advance its Cryospray(TM) Therapies for Esophageal Disease and COPD
HSMN NewsFeed - 2 Oct 2018
Titan Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
Titan Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
HSMN NewsFeed - 18 Sep 2018
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
HSMN NewsFeed - 18 Sep 2018
TranS1(R) Announces NICE Guidance for Approval of AxiaLIF(R) in the UK's National Health System (NHS)
TranS1(R) Announces NICE Guidance for Approval of AxiaLIF(R) in the UK's National Health System (NHS)
HSMN NewsFeed - 17 Sep 2018
Livongo Announces First Cellular-Enabled Blood Pressure Monitoring System in U.S.
Livongo Announces First Cellular-Enabled Blood Pressure Monitoring System in U.S.
HSMN NewsFeed - 11 Sep 2018
Codiak BioSciences Names Robert M. Brenner, M.D. Executive Vice President, Research and Development
Codiak BioSciences Names Robert M. Brenner, M.D. Executive Vice President, Research and Development
HSMN NewsFeed - 6 Sep 2018
Aileron Therapeutics Announces the Appointment of Dr. Manuel Aivado as Chief Executive Officer
Aileron Therapeutics Announces the Appointment of Dr. Manuel Aivado as Chief Executive Officer
HSMN NewsFeed - 30 Aug 2018
REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease
REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease
HSMN NewsFeed - 28 Aug 2018
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
HSMN NewsFeed - 28 Aug 2018
ArcherDX, Inc. Appoints Marvin H. Caruthers, Ph.D., to its Board of Directors
ArcherDX, Inc. Appoints Marvin H. Caruthers, Ph.D., to its Board of Directors
HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Obtains Debt Facility from Silicon Valley Bank to Acquire and Advance Momelotinib
Sierra Oncology Obtains Debt Facility from Silicon Valley Bank to Acquire and Advance Momelotinib
HSMN NewsFeed - 22 Aug 2018
Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard(R)
Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard(R)
HSMN NewsFeed - 21 Aug 2018
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
HSMN NewsFeed - 9 Aug 2018
MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia
MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia
HSMN NewsFeed - 25 Jul 2018
Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact(R) System
Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact(R) System
HSMN NewsFeed - 23 Jul 2018
Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution
Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution
HSMN NewsFeed - 13 Jul 2018
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY(TM) (romosozumab) To The US FDA
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY(TM) (romosozumab) To The US FDA
HSMN NewsFeed - 9 Jul 2018
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
HSMN NewsFeed - 29 Jun 2018
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
HSMN NewsFeed - 28 Jun 2018
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
HSMN NewsFeed - 27 Jun 2018
ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP
ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP
HSMN NewsFeed - 21 Jun 2018
Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India
Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India
HSMN NewsFeed - 20 Jun 2018
Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
HSMN NewsFeed - 20 Jun 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
HSMN NewsFeed - 15 Jun 2018
MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress
MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress
HSMN NewsFeed - 13 Jun 2018
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
HSMN NewsFeed - 11 Jun 2018
Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update
Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update
HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
HSMN NewsFeed - 4 Jun 2018
Codiak BioSciences Names Richard Brudnick Chief Business Officer and Head of Strategy
Codiak BioSciences Names Richard Brudnick Chief Business Officer and Head of Strategy
HSMN NewsFeed - 25 May 2018
Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
HSMN NewsFeed - 23 May 2018
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
HSMN NewsFeed - 22 May 2018
Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
HSMN NewsFeed - 15 May 2018
Amneal Introduces First Generic for Mephyton(R) (Phytonadione) Tablets, 5mg
Amneal Introduces First Generic for Mephyton(R) (Phytonadione) Tablets, 5mg
HSMN NewsFeed - 15 May 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
HSMN NewsFeed - 8 May 2018
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
HSMN NewsFeed - 7 May 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
HSMN NewsFeed - 3 May 2018
Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
HSMN NewsFeed - 23 Apr 2018
Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
Additional items found! 500

Members Archive contains
500 additional stories matching:
RRa
(Password required)
RRa
(Password required)